These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22028268)

  • 1. [Diverse histological lesions in a patient with antiphospholipid syndrome (APS)].
    Salvatore E; Luciani R; Di Palma A; Aversano A; Stellato D; Liuzzi M; Iele E; Martignetti V; Spagnuolo E; Morrone L
    G Ital Nefrol; 2011; 28(5):537-40. PubMed ID: 22028268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid syndrome (APS) nephropathy in catastrophic, primary, and systemic lupus erythematosus-related APS.
    Tektonidou MG; Sotsiou F; Moutsopoulos HM
    J Rheumatol; 2008 Oct; 35(10):1983-8. PubMed ID: 18688914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicomorphological features of nephropathy in primary and secondary antiphospholipid syndrome].
    Kozlovskaia NL; Shilov EM; Meteleva NA; Varshavskiĭ VA; Kushnir VV; Shakhnova EA; Miroshnichenko NG; Serova AG; Nesterova SG
    Ter Arkh; 2007; 79(6):16-25. PubMed ID: 17684961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological features of antiphospholipid nephropathy in patients with Systemic Lupus Erythematosus.
    Naseeb F; Arfaj AA; Hamdani A; Kfoury H; Parvez K; Mogairen SA
    J Coll Physicians Surg Pak; 2015 May; 25(5):332-6. PubMed ID: 26008657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Case of primary antiphospholipid antibody syndrome with repeated renal biopsies].
    Kogure T; Noguchi J; Yanagisawa N; Haizuka H; Sato M
    Nihon Jinzo Gakkai Shi; 2005; 47(4):445-50. PubMed ID: 15971887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catastrophic exacerbation of antiphospholipid syndrome after lung adenocarcinoma biopsy.
    Yamamoto T; Ito M; Nagata S; Suzuki H; Togawa A; Nagase M; Hishida A
    J Rheumatol; 2000 Aug; 27(8):2035-7. PubMed ID: 10955349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vasculopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome].
    Alekberova ZS; Reshetniak TM; Rodenska-Lopovok SG; Aleksandrova EN; Kalashnikova LA; Nasonov EL; Mach ES; Nasonova VA
    Ter Arkh; 1995; 67(5):41-4. PubMed ID: 7638777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome.
    Lopez LR; Dier KJ; Lopez D; Merrill JT; Fink CA
    Am J Clin Pathol; 2004 Jan; 121(1):142-9. PubMed ID: 14750252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal involvement in primary antiphospholipid syndrome.
    Amigo MC; Garcia-Torres R; Robles M; Bochicchio T; Reyes PA
    J Rheumatol; 1992 Aug; 19(8):1181-5. PubMed ID: 1404151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expanding spectrum of renal diseases associated with antiphospholipid syndrome.
    Fakhouri F; Noël LH; Zuber J; Beaufils H; Martinez F; Lebon P; Papo T; Chauveau D; Bletry O; Grünfeld JP; Piette JC; Lesavre P
    Am J Kidney Dis; 2003 Jun; 41(6):1205-11. PubMed ID: 12776272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and treatment of APS renal involvement.
    Tektonidou MG
    Lupus; 2014 Oct; 23(12):1276-8. PubMed ID: 25228725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid antibodies and renal involvement.
    Gigante A; Gasperini ML; Cianci R; Barbano B; Giannakakis K; Di Donato D; Fuiano G; Amoroso A
    Am J Nephrol; 2009; 30(5):405-12. PubMed ID: 19713697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney disease in antiphospholipid syndrome.
    Amigo MC
    Rheum Dis Clin North Am; 2006 Aug; 32(3):509-22. PubMed ID: 16880081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Systemic lupus erythematosus and antiphospholipid syndrome].
    Gröne HJ
    Verh Dtsch Ges Pathol; 1996; 80():21-37. PubMed ID: 9065004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What nephrologists need to know about antiphospholipid syndrome.
    Alchi B; Griffiths M; Jayne D
    Nephrol Dial Transplant; 2010 Oct; 25(10):3147-54. PubMed ID: 20587422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.